Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial-Eligible Populations

Ann Am Thorac Soc. 2021 Sep;18(9):1580-1584. doi: 10.1513/AnnalsATS.202010-1349RL.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / epidemiology
  • Cardiovascular Diseases* / epidemiology
  • Humans

Substances

  • Anti-Asthmatic Agents